



BG Research Online 
 
Postavaru, G-I., Myers, B, Ahmed, T, Lewins, D, Brown, R and Swaby, 
H. (2021) A study protocol to explore and improve access to medical services 
and information for recently diagnosed elderly patients with cancer in rural 
settings. International Journal of Surgery Protocols. ISSN 2468-3574 
This is an manuscript accepted by Elsevier on 13th April 2021.  
This version may differ slightly from the final published version. 
Copyright is retained by the author/s and/or other copyright holders. 
 
End users generally may reproduce, display or distribute single copies of content held within BG 
Research Online, in any format or medium, for personal research & study or for educational or other 
not-for-profit purposes provided that: 
• The full bibliographic details and a hyperlink to (or the URL of) the item’s record in BG Research 
Online are clearly displayed; 
• No part of the content or metadata is further copied, reproduced, distributed, displayed or 
published, in any format or medium; 
• The content and/or metadata is not used for commercial purposes; 
• The content is not altered or adapted without written permission from the rights owner/s,  
unless expressly permitted by licence.  
 






A study protocol to explore and improve access to medical services and information for recently 
diagnosed elderly patients with cancer in rural settings  
 
Abstract 
Introduction: This two-phase exploratory research study seeks to contribute to research in the field 
of rural cancer health; specifically, the aim is to gain insight into the experiences of seeking, 
accessing and using information and health services throughout the cancer journey (diagnosis, 
treatment and follow-up care) for recently diagnosed (≤ 6 months) older patients (≥ 65 years) in 
rural areas.  
Methods and analysis: Data will be collected through in-depth semi-structured interviews. In phase 1 
(before 23rd March 2020) interviews were conducted with healthcare professionals (HCP) to explore 
their experiences of delivering care to their elderly patients. In the second phase (starting January 
2021) we will conduct interviews with cancer patients to understand the impact of COVID-19 and 
shielding on their experiences of being diagnosed, attending appointments and accessing and 
receiving support from community organisations and informal support from family and friends. Data 
gathered will be analysed using the Framework Method. 
Ethics: The study has been approved by the Health Research Authority and the United Lincolnshire 
Hospitals NHS Trust. Initial favourable ethical opinion was granted on 1st October 2019. Second 
favourable ethical opinion for amendments to reflect the impact of COVID-19 was received on 10th 
August 2020. The study protocol has been registered on Research Registry.  
1. Methods and Analysis 
1.1. Study setting and participants 
Healthcare professionals and recently diagnosed cancer patients will be recruited in Lincolnshire 
through medical and local patient organisations.  
1.2. Sampling method 
A purposive and snowballing sampling strategy is used based upon recommendations in the 
literature [1]. Ongoing debate exists around sample sizes and data saturation in qualitative research, 
with some authors recommending a sample size of at least 12 [2]. Little that is ‘new’ arises out of 
transcripts of interviews with 20 or so people [3]. The principle of saturation [4] will be used in that 
the data collection will stop when new data does not shed any further light on the research topic 
[5,6]. 
Principal exclusion criteria for cancer patients are: 1. Advanced cancer; 2. Age <65 years when 
diagnosed and receiving treatment; 3. Diagnosis under investigation but not yet confirmed by HCP; 
4. >6 months since diagnosis; 5. Urban living <10 miles from treatment centre; 6. Lacking capacity to 
consent for themselves due to illnesses involving severe cognitive impairment (e.g. dementia, 
Alzheimer, Parkinson etc); 7. Not able to understand and communicate in English. 
1.3 Procedure  
Table 1 below highlights the steps followed by participants as part of the research protocol. 






















   
Telephone call to prospective HCP participant to discuss 
the study, eligibility criteria, answer questions, and 
arrange an interview 
1 15 minutes 
Participants will be explained in person the Patient 
Information Sheet and Consent Form. Interview consent 
form completed in printed forms by potential 
participants and returned to researcher 
1 30 minutes 
Face to face, in-depth and semi-structured interviews 
with HCP participant (includes debriefing) 







Patient participants’ pre-screening: in person by clinical 
teams or via email/telephone by the researcher  
1 5 minutes 
Telephone call to prospective patient participant to 
discuss the study, eligibility criteria, answer questions, 
and arrange an  interview 
1 15 minutes 
Participants will be sent an electronic study information 
pack explaining the Patient Information Sheet and 
Consent Form. Verbal consent will be obtained and 
recorded with audio recording equipment prior to data 
collection 
1 30 minutes 
In-depth and semi-structured interviews with  patient  
participant over telephone, WhatsApp or Skype 
1 60 minutes 
 
1.4 Data collection method 
1.4.1 Data collected in phase 1 
• Face to face in-depth and semi-structured interviews have been conducted with 17 
healthcare professionals and their colleagues (including oncologists/ haematologists and 
Macmillan nurse specialists, medical secretaries, Cancer services attending Multidisciplinary 
Team Meetings) to explore their experiences of providing information and advice to this 
category of patients.  
1.4.2 Data to be collected in phase 2 
• Phone, WhatsApp or Skype interviews with approximately 20 cancer patients to understand 
their experiences of accessing and receiving effective and timely information from health 
providers within the past 6 months.   
• Clinical care teams and patient organisations’ peer leaders will be made aware of the study 
and will make the initial approach to patients. They will identify, screen and recruit cancer 
patients to the study. Communication with the clinical care teams and patient organisations 
will take place by phone and email. Due to COVID-19 restrictions, potential participants can 
be contacted if after reading the study advertisement or invitation letter they have e-mailed 
the lead investigator or have verbally communicated with a member of the clinical care 
team to explicitly express their interest in the study. Participants will be given a minimum of 
24 hours to decide if they wish to take part in the study. No participant will be contacted by 
the research team without their prior permission. 
• After participants have expressed their interest in the study, the lead researcher will provide 
them with an electronic study information pack (including invitation letter, expression of 
interest form, information sheet, eligibility criteria and consent form). The researcher will 
give potential participants an opportunity to ask questions and discuss the study before 
deciding if they wish to consent to participate. The patient pre-screening process will be 
conducted either by the lead researcher (via the telephone, WhatsApp or Skype) or in 
person by a member of the clinical care team when they approach the patients. Interviews 
will only be arranged once the pre-screening process has been conducted and the 
participant has had chance to discuss the study and eligibility criteria and give their verbal 
consent.  
• Verbal consent will be obtained and recorded with audio recording equipment prior to data 
collection. Those who consent to take part in the study will individually attend one 60 
minute interview which will be digitally recorded.  
1.4.3 Interview questions 
Patient interview questions focused will focus on: the experience of being diagnosed during the 
COVID-19 pandemic; management of transport, appointments and finances; access to healthcare 
services and information; and support seeking behaviours including access to and use of community 
support and help from family and friends. Examples of interview questions included:  
• When were you first told that you had cancer and that you would need to have cancer 
treatment?  
• I am wondering if accessing appointments or travelling to and from the hospital has been 
easier or harder than you anticipated. 
• Can you also tell about anything that may have worried you when accessing healthcare 
services in relation to your diagnosis and treatment?  
• Where do you seek information regarding your diagnosis and treatment?  
• What strategies and resources in your community do you use to manage your diagnosis and 
treatment? 
Interviews with healthcare professionals explored their work experience and communication with 
elderly patients in rural settings, barriers and facilitators to delivering timely healthcare and 
recommendations for service improvement. Some examples of interview questions are:  
• How are you currently able to address your patients’ age-related needs in your practice?  
• In your experience, do you feel your older patients living in rural settings can easily access 
healthcare services or attend their appointments? 
• Thinking about your rural older patients’ care needs and barriers to timely information and 
healthcare– What would improve their healthcare experience?  
• I am wondering if in your practice you are able to work with other professionals (including 
local organisations such as Good Neighbour Schemes) to assist in rural areas.  
• How are you currently able to identify if any of your older patients in rural areas experience 
loneliness and social isolation? 
1.5 Analytic strategy 
The interview data will be analysed using the Framework Method [7]. A jointly developed set of 
codes will be organised into categories to manage and organise the data. The framework will create 
a new structure for the data, summarising it in a way that can support answering the research 
questions [8]. This will be achieved by using a Framework Method matrix of summarised data, which 
will be reviewed during the analysis. Connections within and between participants and categories 
will be made in order to generate themes from the data set. This process will be influenced both by 
the original research objectives and by new concepts generated inductively from the data [8]. 
2. Background and Aims 
Elderly cancer patients in rural settings are at high risk of health inequalities due to barriers to 
accessing timely information and care. Rural populations are ageing “faster” than their urban 
counterparts [9], thus a higher percentage of elderly people are likely to live in rural areas [10]. Two 
thirds of newly diagnosed patients with different medical conditions in the United Kingdom (UK) are 
over the age of 65 [11]. In Lincolnshire, over half (52%) of the county's older population lives in rural 
areas [10]. The UK has some of the lowest survival rates in Europe for people aged 65 and over (Munro, 
2014), partly due to late diagnosis or under treatment [12]. Patients typically present their symptoms 
at a later stage which reduces the chances of survival.  
Frailty, transportation challenges, lack of disposable income and need of assistance with health 
literacy [13], incontinence, co-morbidities or co-dependency may prevent this patient group from 
accessing services and attending appointments relating to their diagnosis, treatment and after-care. 
In addition, social distancing measures introduced to control the spread of COVID-19 and anxieties 
about contracting the virus have negatively impacted patients’ health-seeking behaviours [14]. 
Notably, those who were socially vulnerable before the pandemic now experience more isolation and 
lack of professional advice on how to mitigate treatment side-effects, or how to cope with the 
emotional and physical impact of cancer after treatment. 
Although contact with health providers by telephone or e-mail is available, often these patients are 
uncomfortable with this, particularly when they are hearing-impaired or not able to use electronic 
devices. Inadequate communication between people affected by cancer and health providers is a 
common barrier to cancer care [15], leading to health disparities, poorer adjustment to illness [16] and 
lower survival [17].  
There are knowledge gaps in service provision within the context of COVID-19, for example 
understanding the potential impact of shielding upon the health seeking behaviour of rural patients 
aged 65 and over who have been diagnosed with cancer in the previous 6 months. Understanding the 
impact of older patients’ social circumstances and their health literacy and access to medical services 
is a matter of urgency in the UK [17,18]. With such knowledge gaps, it is difficult to assess the specific 
unmet needs of this group in order to improve their health literacy and communication with health 
providers, reduce health inequality, and empower them to make informed decisions regarding their 
health. This study aligns with the top key priorities launched by the National Cancer Research Institute 
and James Lind Alliance in November 2018, to understand how service delivery can take a more 
personalised approach. 
2.1 Aims 
We aim (a) to identify and explore the potential impact of COVID-19 and shielding upon the needs, 
concerns and preferences that newly diagnosed elderly patients have in relation to how, when and 
what they communicate with their health professionals; (b) to understand the facilitators of and 
barriers to effective and timely access to information and advice from health professionals; (c) map 
key health seeking behaviours and decisions this group of patients make in relation to their 
treatment and care after treatment; and finally (d) to explore patients and health professionals’ 
views on improving health information literacy and access to timely services. 
3. Ethical and regulatory considerations 
NHS ethics and Health Research Authority study approval have been obtained. The study complies 
with the Data Protection Act (1998) and the General Data Protection Regulation (2018) with regards 
to the collection, storage, processing and disclosure of personal information. Data protection NHS 
and Trust policies, the UK legislation and the principles of Caldicott guardian govern any access to 
patient data. We will follow Good Clinical Practice guidelines as members of the research team have 
received training provided by the National Institute for Health Research. A data management plan 
and a study file have been developed and maintained throughout the study to ensure the secure and 
ethical handling of research data and to mitigate any risk of loss to confidential information. 
Electronic data will be stored on secure network drives (e.g. OneDrive) which require system user 
login to access, or stored within the secure EDGE database, and will only be accessible by the 
immediate study team and regulatory bodies. Data will not be disclosed to third parties. Our study 
adheres to equality and diversity principles to reduce barriers to participation in research, especially 
those from protected groups. A risk register will be maintained throughout the study, ensuring any 
issues are acted upon and addressed promptly. 
3.1 Patient and Public Involvement/Engagement 
Aligning with the NHS Age Equality Practice Guide and Macmillan ‘Recovery Package’ Programme, 
this project will draw on specialist knowledge and patient experience. The Lincolnshire Research 
Patient & Public Forum is part of the project steering group and has ensured that our approach is 
sufficiently sensitive towards the needs of those diagnosed with cancer. One of the members of the 
Forum is a member of the project core team. In order to strive for a high standard of ethical research 
practice, and ensure that the data collection process is sensitive and inclusive, the Lincolnshire 
Patient and Public Forum, a Macmillan representative and a senior HCP with extensive research 
experience in cancer research reviewed the research pack (interview questions, consent forms, 
information and debrief sheets) to ensure external validation and quality check. Consideration was 
given to the nature of the study, terminology and interview guides. The process was guided by 
review forms completed by all members involved. 
4. Dissemination 
Our aim is to publish at least two academic papers (e.g. Primary Care, BMC Public Health and 
Psycho-oncology/ Psychology and Health) and to present at conferences organised by the British and 
International Psychosocial Oncology Society. We will produce research briefings and flyers in relation 
to these academic outputs for distribution across support groups and will give presentations to 
patient representative groups in rural areas. Finally, we will feedback the Macmillan Clinical 
Commissioning Group, to explore new ways of delivering health messages as part of a larger service 
improvement programme, with the ultimate aim of improving services aimed at tackling the 
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